Case number 2022-1482
Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 12, 2024 | 60 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [976384] [MVH] [Entered: 01/12/2024 12:35 PM] (1) |
| Nov 26, 2023 | 0 | PURDUE PHARMA L.P. v. COLLEGIUM PHARMACEUTICAL, INC. [OPINION] [precedential] (0) |
| Nov 21, 2023 | 59 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [964805] [MVH] [Entered: 11/21/2023 10:26 AM] (1) |
| Nov 21, 2023 | 58 | OPINION filed for the court by Dyk, Circuit Judge; Hughes, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [964804] [MVH] [Entered: 11/21/2023 10:26 AM] (15) |
| Oct 31, 2023 | 57 | Notice from Intervenor Katherine K. Vidal of Withdrawal of Director's Counsel (Thomas W. Krause). Service: 10/31/2023 by email. [960215] [22-1482] [Farheena Rasheed] [Entered: 10/31/2023 06:48 AM] (1) |
| Sep 5, 2023 | 56 | Submitted after ORAL ARGUMENT to Panel: Dyk, Circuit Judge; Hughes, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: Jennifer L. Swize for Purdue Pharma L.P. and Purdue Pharmaceuticals L.P., Christopher A. Pinahs for Collegium Pharmaceutical, Inc. and Farheena Yasmeen Rasheed for Katherine K. Vidal.Oral Argument Audio available here. [947756] [MJL] [Entered: 09/05/2023 04:26 PM] (0) |
| Aug 9, 2023 | 55 | Corrected Response to notice of oral argument from Appellee Collegium Pharmaceutical, Inc.. Service: 08/09/2023 by email. [941909] [22-1482] [Christopher Pinahs] [Entered: 08/09/2023 06:44 PM] (1) |
| Aug 9, 2023 | 54 | Corrected Response to notice of oral argument from Appellee Collegium Pharmaceutical, Inc.. Service: 08/09/2023 by email. [941854] [22-1482] [Christopher Pinahs] [Entered: 08/09/2023 04:12 PM] (1) |
| Aug 9, 2023 | 53 | Corrected Response to notice of oral argument from Intervenor Katherine K. Vidal. Service: 08/09/2023 by email. [941638] [22-1482] [Farheena Rasheed] [Entered: 08/09/2023 07:03 AM] (1) |
| Aug 7, 2023 | 52 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: The responses to notice of oral argument (RNOAs) filed by Intervenor [49] and Appellee [50] identify a division of time that exceeds the maximum of 15 minutes authorized for the responsive side. CORRECTION: No later than 08/14/2023, Appellee and Intervenor are directed to file corrected RNOAs accounting for a division of time that does not exceed 15 minutes. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [940946] [MJL] [Entered: 08/07/2023 09:37 AM] (0) |
| Aug 4, 2023 | 51 | Response to notice of oral argument from Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 08/04/2023 by email. [940775] [22-1482] [Jennifer Swize] [Entered: 08/04/2023 01:35 PM] (1) |
| Aug 4, 2023 | 50 | Response to notice of oral argument from Appellee Collegium Pharmaceutical, Inc.. Service: 08/04/2023 by email. [940768] [22-1482] [Christopher Pinahs] [Entered: 08/04/2023 01:22 PM] (1) |
| Aug 3, 2023 | 49 | Response to notice of oral argument from Intervenor Katherine K. Vidal. Service: 08/03/2023 by email. [940383] [22-1482] [Farheena Rasheed] [Entered: 08/03/2023 09:55 AM] (1) |
| Jul 21, 2023 | 48 | NOTICE OF ORAL ARGUMENT. Panel: 2309B. Case scheduled September 5, 2023. Response to Notice of Oral Argument due: 08/04/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [937647] [MVH] [Entered: 07/21/2023 02:02 PM] (2) |
| Apr 11, 2023 | 47 | The following additional conflict dates submitted by Jennifer L. Swize for Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. have been accepted by the court: 06/05/2023, 06/06/2023, 06/07/2023, 06/08/2023, 06/09/2023. [915993] [MJL] [Entered: 04/11/2023 01:55 PM] (0) |
| Apr 6, 2023 | 46 | Notice from Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. regarding conflicts with oral argument. Service: 04/06/2023 by email. [915002] [22-1482] [Jennifer Swize] [Entered: 04/06/2023 02:05 PM] (4) |
| Feb 10, 2023 | 45 | The following conflict dates submitted by Jennifer L. Swize for Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. have been accepted by the court: 07/10/2023, 07/11/2023, 07/12/2023, 07/13/2023, 07/14/2023. [903380] [MJL] [Entered: 02/10/2023 09:02 AM] (0) |
| Feb 7, 2023 | 44 | Notice from Appellants Purdue Pharmaceuticals L.P. and Purdue Pharma L.P. regarding conflicts with oral argument. Service: 02/07/2023 by email. [902685] [22-1482] [Jennifer Swize] [Entered: 02/07/2023 04:31 PM] (2) |
| Jan 24, 2023 | 42 | The following conflict dates submitted by Christopher A. Pinahs for Collegium Pharmaceutical, Inc. have been accepted by the court: 03/06/2023, 03/07/2023, 03/08/2023, 04/03/2023, 04/04/2023. [899006] [MJL] [Entered: 01/24/2023 10:51 AM] (0) |
| Jan 20, 2023 | 43 | 6 paper copies of Doc. No. [28] received from Katherine K. Vidal. (Night Box). [899299] [MJL] [Entered: 01/24/2023 05:02 PM] (0) |
| Jan 18, 2023 | 41 | Notice from Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. regarding conflicts with oral argument. Service: 01/18/2023 by email. [897852] [22-1482] [Jennifer Swize] [Entered: 01/18/2023 09:31 PM] (1) |
| Jan 18, 2023 | 40 | Notice from Appellee Collegium Pharmaceutical, Inc. regarding conflicts with oral argument. Service: 01/18/2023 by email. [897839] [22-1482] [Christopher Pinahs] [Entered: 01/18/2023 06:27 PM] (1) |
| Jan 17, 2023 | 39 | 6 paper copies of Doc. No. [28] received from Intervenor Katherine K. Vidal. [897726] [VDW] [Entered: 01/18/2023 02:44 PM] (0) |
| Jan 17, 2023 | 38 | 6 paper copies of Doc. No. [23] received from Appellee Collegium Pharmaceutical, Inc.. [897337] [VDW] [Entered: 01/17/2023 01:31 PM] (0) |
| Jan 17, 2023 | 36 | Notice from Intervenor Katherine K. Vidal regarding conflicts with oral argument. None. Service: 01/17/2023 by email. [897331] [22-1482] [Farheena Rasheed] [Entered: 01/17/2023 01:10 PM] (0) |
| Jan 13, 2023 | 37 | 6 paper copies of Doc. No. [33], [31], [18] received from Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [897335] [VDW] [Entered: 01/17/2023 01:28 PM] (0) |
| Jan 11, 2023 | 35 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [896250] [KMH] [Entered: 01/11/2023 12:09 PM] (0) |
| Jan 11, 2023 | 34 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [896249] [KMH] [Entered: 01/11/2023 12:07 PM] (1) |
| Dec 29, 2022 | 33 | MODIFIED ENTRY: APPENDIX FILED by Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Appellee Collegium Pharmaceutical, Inc. and Intervenor Katherine K. Vidal. Service: 12/29/2022 by email. [893637] --[Edited 01/10/2023 by KMH - compliance review complete] [Jennifer Swize] [Entered: 12/29/2022 02:17 PM] (497) |
| Dec 27, 2022 | 32 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Collegium Pharmaceutical, Inc. and Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/27/2022 by email. [893086] [22-1482] [Jennifer Swize] [Entered: 12/27/2022 02:24 PM] (2) |
| Dec 22, 2022 | 31 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 12/22/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [892566] --[Edited 01/06/2023 by KMH - compliance review complete] [Jennifer Swize] [Entered: 12/22/2022 05:28 PM] (39) |
| Dec 6, 2022 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. The reply brief is due 12/22/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [888821] [KMH] [Entered: 12/06/2022 04:31 PM] (0) |
| Dec 1, 2022 | 29 | MOTION of Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 12/22/2022 to file brief. Service: 12/01/2022 by email. [887511] [22-1482] [Jennifer Swize] [Entered: 12/01/2022 12:01 PM] (6) |
| Nov 21, 2022 | 28 | MODIFIED ENTRY: INTERVENOR BRIEF FILED by Intervenor Katherine K. Vidal. Service: 11/21/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [885679] --[Edited 12/06/2022 by KMH - compliance review complete] [Farheena Rasheed] [Entered: 11/21/2022 06:22 PM] (52) |
| Nov 10, 2022 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file brief [26] filed by Intervenor Katherine K. Vidal. The intervenor brief is due 11/21/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [883390] [KMH] [Entered: 11/10/2022 10:40 AM] (0) |
| Nov 7, 2022 | 26 | MOTION of Intervenor Katherine K. Vidal to extend the time to 11/21/2022 to file brief. Service: 11/07/2022 by email. [882591] [22-1482] [Farheena Rasheed] [Entered: 11/07/2022 02:57 PM] (3) |
| Oct 5, 2022 | 25 | Docketing Statement for the Intervenor Katherine K. Vidal. Service: 10/05/2022 by email. [875998] [22-1482] [Farheena Rasheed] [Entered: 10/05/2022 10:04 AM] (2) |
| Oct 3, 2022 | 24 | ORDER filed granting [21] the motion. The revised official caption is reflected above. Intervenor is directed to file a docketing statement no later than 14 days from the date of filing of this order. Intervenor's brief is due within 40 days of the date of filing of this order. Appellants' reply brief is due no later than 21 days from the date of filing of intervenor's brief. Service as of this date by the Clerk of Court. [875338] [LMS] [Entered: 10/03/2022 11:59 AM] (2) |
| Sep 28, 2022 | 23 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Collegium Pharmaceutical, Inc.. Service: 09/28/2022 by email. [874411] --[Edited 10/05/2022 by KMH - compliance review complete] [Jacob Holdreith] [Entered: 09/28/2022 12:46 PM] (74) |
| Sep 7, 2022 | 22 | Entry of appearance for Farheena Y. Rasheed; Thomas W. Krause; Peter J. Ayers; Maureen D. Queler as counsel for U.S. Patent and Trademark Office. Service: 09/07/2022 by email. [870278] [22-1482] [Farheena Rasheed] [Entered: 09/07/2022 09:49 AM] (2) |
| Sep 7, 2022 | 21 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 09/07/2022 by email. [870273] [22-1482] [Farheena Rasheed] [Entered: 09/07/2022 09:45 AM] (2) |
| Jul 27, 2022 | 20 | **TEXT ONLY** ORDER granting motion to extend time to file brief [19] filed by Appellee Collegium Pharmaceutical, Inc. The response brief is due 09/28/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [863259] [JCW] [Entered: 07/27/2022 08:46 AM] (0) |
| Jul 26, 2022 | 19 | MOTION of Appellee Collegium Pharmaceutical, Inc. to extend the time to 09/28/2022 to file brief. Service: 07/26/2022 by email. [863221] [22-1482] [Brenda Joly] [Entered: 07/26/2022 04:56 PM] (8) |
| Jul 19, 2022 | 18 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. Service: 07/19/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [861927] --[Edited 07/20/2022 by JCW - compliance review complete] [Jennifer Swize] [Entered: 07/19/2022 07:54 PM] (196) |
| May 20, 2022 | 17 | ORDER filed denying [12] motion to terminate appeal filed by Collegium Pharmaceutical, Inc.; The parties are directed to address jurisdiction in their briefs. Purdue's opening brief is due no later than 60 days from the date of filing of this order. Service as of this date by the Clerk of Court. [850979] [LMS] [Entered: 05/20/2022 12:44 PM] (2) |
| Apr 29, 2022 | 16 | REPLY of Appellee Collegium Pharmaceutical, Inc. to response [13]. Service: 04/29/2022 by email. [846479] [22-1482] [Jacob Holdreith] [Entered: 04/29/2022 03:43 PM] (16) |
| Apr 28, 2022 | 15 | ORDER granting motion to withdraw attorney [14] filed by Appellee Collegium Pharmaceutical, Inc. Service as of this date by the Clerk of Court. [845942] [NL] [Entered: 04/28/2022 10:12 AM] (2) |
| Apr 25, 2022 | 14 | MOTION of Appellee Collegium Pharmaceutical, Inc. to withdraw counsel Kelsey J. McElveen. Service: 04/25/2022 by email. [845285] [22-1482] [Jacob Holdreith] [Entered: 04/25/2022 05:05 PM] (5) |
| Apr 22, 2022 | 13 | RESPONSE of Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to Doc No. [12]. Service: 04/22/2022 by email. [845063] [22-1482] [Gregory Castanias] [Entered: 04/22/2022 06:35 PM] (353) |
| Apr 12, 2022 | 12 | MOTION of Appellee Collegium Pharmaceutical, Inc. Dismiss Appeal as Untimely. Service: 04/12/2022 by email. [842611] [22-1482] [Jacob Holdreith] [Entered: 04/12/2022 03:32 PM] (237) |
| Apr 12, 2022 | 11 | Entry of appearance for Emily Tremblay as counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 04/12/2022 by email. [842606] [22-1482] [Emily Tremblay] [Entered: 04/12/2022 02:46 PM] (1) |
| Mar 30, 2022 | 10 | Certified list received. Service: 03/29/2022 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [839845] [JCW] [Entered: 03/30/2022 08:51 AM] (0) |
| Mar 3, 2022 | 9 | Docketing Statement for the Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 03/03/2022 by email. [834768] [22-1482] [Jennifer Swize] [Entered: 03/03/2022 08:12 PM] (0) |
| Mar 3, 2022 | 8 | Certificate of Interest for Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 03/03/2022 by email. [834767] [22-1482] [Jennifer Swize] [Entered: 03/03/2022 08:09 PM] (0) |
| Mar 3, 2022 | 7 | Entry of appearance for Gregory A. Castanias; Jennifer L. Swize; John J. Normile; Gasper J. LaRosa; John Boule, III; Pablo D. Hendler as counsel for Appellants Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 03/03/2022 by email. [834765] [22-1482] [Jennifer Swize] [Entered: 03/03/2022 08:07 PM] (0) |
| Mar 3, 2022 | 6 | Docketing Statement for the Appellee Collegium Pharmaceutical, Inc.. Service: 03/03/2022 by email. [834600] [22-1482] [Brenda Joly] [Entered: 03/03/2022 11:46 AM] (0) |
| Mar 3, 2022 | 5 | Certificate of Interest for Appellee Collegium Pharmaceutical, Inc.. Service: 03/03/2022 by email. [834596] [22-1482] [Brenda Joly] [Entered: 03/03/2022 11:43 AM] (0) |
| Mar 3, 2022 | 4 | Corrected Entry of appearance for Jacob M. Holdreith; Oren D. Langer; Christopher A. Pinahs; Kelsey J. McElveen; Brenda L. Joly as counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 03/03/2022 by email. [834592] [22-1482] [Brenda Joly] [Entered: 03/03/2022 11:37 AM] (0) |
| Mar 3, 2022 | 3 | Corrected Entry of appearance for Brenda L. Joly; Jacob M. Holdreith: Oren D. Langer as counsel for Appellee Collegium Pharmaceutical, Inc. Brenda L. Joly; Jacob M. Holdreith: Oren D. Langer. Service: 03/03/2022 by email. [834573] [22-1482] [Brenda Joly] [Entered: 03/03/2022 11:02 AM] (0) |
| Mar 3, 2022 | 2 | Entry of appearance for Brenda L. Joly as counsel for Appellee Collegium Pharmaceutical, Inc.. Service: 03/03/2022 by email. [834566] [22-1482] [Brenda Joly] [Entered: 03/03/2022 10:51 AM] (0) |
| Feb 17, 2022 | 1 | Appeal docketed. Received: 02/16/2022. [831920] Entry of Appearance is due on 03/03/2022. Certificate of Interest is due on 03/03/2022. Docketing Statement is due on 03/03/2022. Certified List is due on 03/29/2022. [ALK] [Entered: 02/17/2022 11:02 AM] (0) |
